.Groupon Is Way Off (GRPN,BBY,GPN,AVP,THRX)

Groupon Inc (NASDAQ:GRPN) shares declined 12% to $16.16 on an unusual volume of 3.42 million shares, over 2x its average daily volume.  The revised net loss was $65.4 million, or $0.12 per share, on revenue of $492.2 million. In February, the company posted a net loss of $42.7 million, or $0.08 per share, on revenue of $506.5 million for the fourth quarter.
Best Buy Co., Inc. (NYSE:BBY) shares declined 0.46% to $23.57 in the morning hour. The company had reported last week, fourth quarter adjusted earnings from continuing operations of $2.47 per share, as compared to $1.98 per share in the prior year.Additionally, the board of directors of the company has authorized payment of a regular quarterly cash dividend of $0.16 per common share. The quarterly dividend is payable on May 10, 2012 to shareholders of record as of the close of business on April 19, 2012.
Global Payments Inc. (NYSE:GPN) fell 3.75% to $45.72 in the morning hour. The company is currently trading on an above average volume of 2.94 million shares, over 5x its average volume. The company said that the major security breach was under control and affected no more than 1.5 million North American accounts. The hackers took account numbers but did not get access to cardholder names, addresses or Social Security numbers. The information could be used to create bogus credit cards.
Avon Products, Inc. (NYSE:AVP) surged 17.36% to $22.72 in the morning hour after the company rejected Coty's indication of interest is in Avon shareholders' best interests. The company is trading at an unusual volume of 25.41 million share, over 6x times its average volume. The company feels that Coty's offer only represents a 20% premium over Avon's closing share price on March 30, 2012, and does not reflect the fundamental value of Avon and its global beauty care franchise. Coty's indication of interest of $23.25 per share does not provide a compelling reason for Avon to deviate from its current plans.
Theravance Inc (NASDAQ:THRX) shares soared over 15% to $22.60 in the morning hour after GlaxoSmithKline plc (GSK) and Theravance, Inc. announced that they have entered into a stock purchase agreement, under which GSK will acquire, 10,000,000 shares of Theravance common stock at a price of $21.2887 per share, for a total investment of $212,887,000. Following this purchase, GSK would own 25,814,421 shares of Theravance common stock, which would increase GSK's ownership from 18.3% to approximately 26.8% of the total outstanding capital stock of Theravance.